Collaboration Gateway

Partner With MyToHealth

Accelerating neurodegenerative biomarker validation, proprietary assay licensing, and targeted mitochondrial therapeutic discovery alongside scientific leaders.

Initiate a Scientific Collaboration

Submit your technical inquiry or partnership proposal. Our Malvern team will respond within 1-2 business days.

First Name *

Last Name *

Professional / Work Email *

Organization / Institution *

Primary Area of Interest *

Project Scope / Technical Inquiries *

I understand that communications regarding proprietary assay protocols or MTA terms are subject to standard Confidential Disclosure Agreements (CDA).

Business Development Office

Sarah Thomas

Director of Strategic Collaborations

(610) 644-6974 EXT 301
bd@mytohealth.net

Research Facilities

MyToHealth LLC
Great Valley Corporate Center
271 Great Valley Parkway, Suite 400
Malvern, PA 19355, USA

Collaboration Portfolios

pUB Biomarker Diagnostics (AD & PD)
High-Throughput Ligase Assay Screening
Michael J. Fox Foundation Cohort Studies
LabCorp & Reference Lab Assays

STEP 01

Initial Review & CDA

Evaluation of technical alignment and mutual NDA/CDA execution within 48 hours.

STEP 02

Assay & Data Validation

Collaborative scoping of sample cohorts, affinity matrices, or drug screening targets.

STEP 03

Deployment & Execution

Finalizing Material Transfer Agreements (MTA) or long-term clinical licensing agreements.